Ad is loading...
ACB
Price
$4.20
Change
-$0.14 (-3.23%)
Updated
Nov 15 closing price
80 days until earnings call
MEDIF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Ad is loading...

ACB vs MEDIF

Header iconACB vs MEDIF Comparison
Open Charts ACB vs MEDIFBanner chart's image
Aurora Cannabis
Price$4.20
Change-$0.14 (-3.23%)
Volume$1.06M
CapitalizationN/A
Medipharm Labs
Price$0.05
Change-$0.00 (-0.00%)
Volume$84.96K
CapitalizationN/A
ACB vs MEDIF Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACB vs. MEDIF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Sell and MEDIF is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ACB: $4.20 vs. MEDIF: $0.05)
Brand notoriety: ACB: Notable vs. MEDIF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 107% vs. MEDIF: 76%
Market capitalization -- ACB: $238.86M vs. MEDIF: $19.13M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. MEDIF’s [@Pharmaceuticals: Other] market capitalization is $19.13M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileMEDIF’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • MEDIF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEDIF is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish while MEDIF’s TA Score has 2 bullish TA indicator(s).

  • ACB’s TA Score: 4 bullish, 5 bearish.
  • MEDIF’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ACB is a better buy in the short-term than MEDIF.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а -12.86% price change this week, while MEDIF (@Pharmaceuticals: Other) price change was +3.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

ACB is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than MEDIF($19.1M). MEDIF YTD gains are higher at: 5.041 vs. ACB (-11.802). MEDIF has higher annual earnings (EBITDA): -41.42M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. MEDIF (20.2M). MEDIF has less debt than ACB: MEDIF (218K) vs ACB (103M). ACB has higher revenues than MEDIF: ACB (212M) vs MEDIF (22.2M).
ACBMEDIFACB / MEDIF
Capitalization239M19.1M1,251%
EBITDA-1.64B-41.42M3,952%
Gain YTD-11.8025.041-234%
P/E RatioN/AN/A-
Revenue212M22.2M955%
Total Cash149M20.2M738%
Total Debt103M218K47,248%
FUNDAMENTALS RATINGS
ACB vs MEDIF: Fundamental Ratings
ACB
MEDIF
OUTLOOK RATING
1..100
5450
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8992
PRICE GROWTH RATING
1..100
9058
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEDIF's Valuation (93) in the null industry is in the same range as ACB (94) in the Pharmaceuticals Other industry. This means that MEDIF’s stock grew similarly to ACB’s over the last 12 months.

MEDIF's Profit vs Risk Rating (100) in the null industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that MEDIF’s stock grew similarly to ACB’s over the last 12 months.

ACB's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as MEDIF (92) in the null industry. This means that ACB’s stock grew similarly to MEDIF’s over the last 12 months.

MEDIF's Price Growth Rating (58) in the null industry is in the same range as ACB (90) in the Pharmaceuticals Other industry. This means that MEDIF’s stock grew similarly to ACB’s over the last 12 months.

MEDIF's P/E Growth Rating (100) in the null industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that MEDIF’s stock grew similarly to ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBMEDIF
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
76%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AON379.292.96
+0.79%
Aon plc
AGS11.63-0.02
-0.17%
PlayAGS
EFSC58.83-0.25
-0.42%
Enterprise Financial Services Corp
OLLI91.93-0.60
-0.65%
Ollie's Bargain Outlet Holdings
CTSO0.89-0.05
-5.78%
Cytosorbents Corp

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been closely correlated with CGC. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-3.23%
CGC - ACB
82%
Closely correlated
-0.27%
TLRY - ACB
76%
Closely correlated
-2.17%
CRON - ACB
67%
Closely correlated
-2.90%
SNDL - ACB
65%
Loosely correlated
N/A
OGI - ACB
56%
Loosely correlated
-4.00%
More

MEDIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDIF has been loosely correlated with CGC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDIF jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDIF
1D Price
Change %
MEDIF100%
-1.64%
CGC - MEDIF
36%
Loosely correlated
-0.27%
TLRY - MEDIF
28%
Poorly correlated
-2.17%
ACB - MEDIF
24%
Poorly correlated
-3.23%
AAWH - MEDIF
24%
Poorly correlated
-6.81%
GLASF - MEDIF
24%
Poorly correlated
-0.38%
More